11:50 AM EDT, 08/02/2024 (MT Newswires) -- Trinity Biotech ( TRIB ) said Friday it expects Q2 revenue to be around $15.5 million to $16.0 million, compared with $13.9 million a year earlier.

A lone analyst polled by Capital IQ expects $15 million.

The company also said it signed a distribution agreement with MedScience for its clinical chemistry, infectious disease, and autoimmune products in the UK.

Price: 2.73, Change: -0.09, Percent Change: -3.37